NXP Semiconductors Work in process increased by 1.3% to $1.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.0%, from $1.64B to $1.80B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 17.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $882.00M | $894.00M | $846.00M | $974.00M | $1.08B | $1.13B | $1.31B | $1.52B | $1.66B | $1.66B | $1.63B | $1.58B | $1.57B | $1.56B | $1.58B | $1.64B | $1.65B | $1.67B | $1.78B | $1.80B |
| QoQ Change | — | +1.4% | -5.4% | +15.1% | +11.2% | +4.6% | +15.4% | +16.4% | +9.3% | +0.0% | -1.9% | -3.2% | -0.8% | -0.5% | +1.0% | +3.9% | +0.5% | +1.2% | +6.7% | +1.3% |
| YoY Change | — | — | — | — | +22.8% | +26.7% | +54.6% | +56.3% | +53.6% | +46.9% | +24.8% | +3.8% | -5.8% | -6.3% | -3.5% | +3.7% | +5.0% | +6.8% | +12.8% | +10.0% |
| % of Inventories | 79.0% | 76.2% | 71.2% | 74.3% | 74.1% | 71.7% | 73.4% | 77.0% | 79.0% | 77.8% | 76.5% | 75.2% | 73.0% | 69.8% | 66.9% | 69.7% | 69.8% | 67.9% | 69.0% | 71.4% |
| Share Change | — | -2.8pp | -5.1pp | +3.1pp | -0.2pp | -2.4pp | +1.7pp | +3.6pp | +2.0pp | -1.2pp | -1.2pp | -1.4pp | -2.2pp | -3.2pp | -2.9pp | +2.8pp | +0.1pp | -1.8pp | +1.1pp | +2.4pp |